American Oncology Network, Inc. (AONC)

3.7100 -0.0900 (-2.37%) At close: 04:00PM EDT

American Oncology Network, Inc.

14543 Global Parkway
Suite 110
Fort Myers, FL 33913
United States
833-886-1725
https://www.aoncology.com

Sector(s): Healthcare
Industry: Medical Care Facilities
Full Time Employees: 1,525

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Todd Schonherz	CEO & Director	2.25M	N/A	1970
Dr. Stephen Divers M.D.	Chief Medical Officer, VC of Board of Managers & Chairman of Advisory Board Executive Committee	1.7M	N/A	1974
Mr. Mark Moch	Chief Information Officer	N/A	N/A	N/A
Ms. Kristin Matisziw	Chief Compliance & Risk Officer	N/A	N/A	N/A
Ms. Erica Mallon	General Counsel	N/A	N/A	1988
Ms. Caroline Hewitt	Vice President of Marketing	N/A	N/A	N/A
Mr. James Gilmore Pharm.D.	Chief Pharmacy & Clinical Services Officer	N/A	N/A	N/A
Ms. Shelly Glenn	Chief Growth & Relationship Officer	N/A	N/A	N/A
Ms. Karen Pilley	Chief Revenue Cycle Officer	N/A	N/A	N/A
Mr. Anthony V. Belott	Chief Development Officer	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

American Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.

Corporate Governance

American Oncology Network, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.